Feb 01, 2021 7:05am EST Virios Therapeutics, Inc. Announces Research Collaboration to Explore Role of HSV-1 in Irritable Bowel Syndrome
Jan 04, 2021 4:05pm EST Virios Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
Dec 21, 2020 3:00pm EST Virios Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option
Apr 05, 2020 12:00am EDT Virios Therapeutics (Formerly Innovative Med Concepts) Builds Out Leadership Team to Scale Capital and Prepare to Execute Landmark IMC-1 Phase 2b Fibromyalgia Program
